Category: Smith & Nephew
Regulators in the U.K. issue a medical device alert on Smith & Nephew's Renasys negative-pressure wound therapy device, following a field safety notice the company issued last October.
With 20 placements of Mako's surgical robots in the final quarter of 2014, Stryker CEO Kevin Lobo is confident in the $1.7 billion acquisition – and in Stryker's ability to integrate future acquisitions.
Stryker (NYSE:SYK) posted a stellar quarter of sales for the robotic surgical system it acquired in its $1.7 billion deal for Mako Surgical.
Stryker CEO Kevin Lobo says he doesn't view the so-called 'repless' generic sales models piloted by orthopedic rivals Smith & Nephew and Wright Medical as a serious threat.
Amniox Medical names former Smith & Nephew wound care honcho Thomas Dugan to be its new CEO.
, DePuy Synthes Spine
, Echo Therapeutics Inc.
, Johnson & Johnson
, OMNIlife Science Inc.
, Pro-Dex Inc.
, Smith & Nephew
, Tissue Regeneration Systems
, Unilife Corp.
, Arrhythmia Research Technology Inc.
Smith & Nephew says its 'no-frills' Syncera program, which replaces sales reps with an automated system, has performed so well that the company will expand it into Australia, New Zealand and the European Union.
Olivier Bohuon, speaking at the annual JPMorgan conference on healthcare, says the company has decided not to follow consolidation wave.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Stryker could move for Smith & Nephew 'soon'; Zoll Medical to acquire Advanced Circulatory Systems; Judge won't stop Medtronic plan to cover $63m tax tab for execs, directors; Covidien inks deal to settle lawsuit over Medtronic merger; Medtech M&A: Uroplasty, Vision-Sciences to merge